Randel William Woodgrift - 03 Sep 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Randel W. Woodgrift by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
03 Sep 2021
Net transactions value
-$780,750
Form type
4
Filing time
08 Sep 2021, 17:28:20 UTC
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $38,400 +1,000 +2% $38.40 50,093 03 Sep 2021 Direct
transaction ABT Common shares without par value Sale $129,000 -1,000 -2% $129.00 49,093 03 Sep 2021 Direct
transaction ABT Common shares without par value Sale $690,150 -5,350 -11% $129.00 43,743 03 Sep 2021 Direct
holding ABT Common shares without par value 3,217 03 Sep 2021 Profit Sharing Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -1,000 -43% $0.000000 1,333 03 Sep 2021 Common Shares 1,000 $38.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in the Abbott Laboratories Stock Retirement Trust as of September 7, 2021.
F2 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).